NAYA Biosciences Inc. (NAYA)
NAYA Biosciences Statistics
Share Statistics
NAYA Biosciences has 666.06K shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 666.06K |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 1.51K |
| FTD / Avg. Volume | 3.09% |
Short Selling Information
The latest short interest is 6.89K, so 0.14% of the outstanding shares have been sold short.
| Short Interest | 6.89K |
| Short % of Shares Out | 0.14% |
| Short % of Float | 0.14% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -5.99 and the forward PE ratio is -0.59. NAYA Biosciences's PEG ratio is 0.14.
| PE Ratio | -5.99 |
| Forward PE | -0.59 |
| PS Ratio | 15.93 |
| Forward PS | 0.1 |
| PB Ratio | 53.88 |
| P/FCF Ratio | -9.25 |
| PEG Ratio | 0.14 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for NAYA Biosciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.16, with a Debt / Equity ratio of 7.06.
| Current Ratio | 0.16 |
| Quick Ratio | 0.12 |
| Debt / Equity | 7.06 |
| Debt / EBITDA | -0.92 |
| Debt / FCF | -1.21 |
| Interest Coverage | -7.31 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $100.69K |
| Profits Per Employee | $-267.82K |
| Employee Count | 30 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 7.31 |
Taxes
| Income Tax | 27.79K |
| Effective Tax Rate | -0.35% |
Stock Price Statistics
The stock price has increased by -89.47% in the last 52 weeks. The beta is 2.04, so NAYA Biosciences's price volatility has been higher than the market average.
| Beta | 2.04 |
| 52-Week Price Change | -89.47% |
| 50-Day Moving Average | 3.23 |
| 200-Day Moving Average | 7.8 |
| Relative Strength Index (RSI) | 39.17 |
| Average Volume (20 Days) | 48.91K |
Income Statement
In the last 12 months, NAYA Biosciences had revenue of 3.02M and earned -8.03M in profits. Earnings per share was -5.13.
| Revenue | 3.02M |
| Gross Profit | 1.09M |
| Operating Income | -6.77M |
| Net Income | -8.03M |
| EBITDA | -6.88M |
| EBIT | -7.08M |
| Earnings Per Share (EPS) | -5.13 |
Balance Sheet
The company has 232.42K in cash and 6.3M in debt, giving a net cash position of -6.07M.
| Cash & Cash Equivalents | 232.42K |
| Total Debt | 6.3M |
| Net Cash | -6.07M |
| Retained Earnings | -57.82M |
| Total Assets | 17.02M |
| Working Capital | -6.7M |
Cash Flow
In the last 12 months, operating cash flow was -4.76M and capital expenditures -444.72K, giving a free cash flow of -5.2M.
| Operating Cash Flow | -4.76M |
| Capital Expenditures | -444.72K |
| Free Cash Flow | -5.2M |
| FCF Per Share | -1.66 |
Margins
Gross margin is 35.96%, with operating and profit margins of -224.04% and -266%.
| Gross Margin | 35.96% |
| Operating Margin | -224.04% |
| Pretax Margin | -265.08% |
| Profit Margin | -266% |
| EBITDA Margin | -227.77% |
| EBIT Margin | -224.04% |
| FCF Margin | -172.15% |
Dividends & Yields
NAYA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for NAYA is $24, which is 1150% higher than the current price. The consensus rating is "Buy".
| Price Target | $24 |
| Price Target Difference | 1150% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Mar 18, 2025. It was a backward split with a ratio of 1:12.
| Last Split Date | Mar 18, 2025 |
| Split Type | backward |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | -6.52 |
| Piotroski F-Score | 2 |